CUV — Clinuvel Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- AU$381.23m
- AU$131.12m
- AU$94.02m
Australia Stock Exchange release from CLINUVEL PHARMAC : PRE_NR Ends: 09:45:24
Australia Stock Exchange release from CLINUVEL PHARMAC : PRE_NR Ends: 09:26:25
Australia Stock Exchange release from CLINUVEL PHARMAC : afamelanotide in Stroke (AIS) - Positive Preliminary Results
Jefferies sees promise in ongoing trials, approvals of Clinuvel; raises PT
Australia Stock Exchange release from CLINUVEL PHARMAC : Change of Director's Interest Notice
Australia Stock Exchange release from CLINUVEL PHARMAC : CEO Letter
Australia Stock Exchange release from CLINUVEL PHARMAC : CLINUVEL Reports December Half Year Operating Results
Australia Stock Exchange release from CLINUVEL PHARMAC : PRE_NR Ends: 10:02:33
Australia Stock Exchange release from CLINUVEL PHARMAC : Appendix 4D Half Year Report
Australia Stock Exchange release from CLINUVEL PHARMAC : PRE_NR Ends: 09:52:03
Australia Stock Exchange release from CLINUVEL PHARMAC : Operations Update I Financial Results Webinar
Australia Stock Exchange release from CLINUVEL PHARMAC : CLINUVEL Expands DNA Repair Program with 2nd Study
Australia Stock Exchange release from CLINUVEL PHARMAC : Quarterly Activities/Appendix 4C Cash Flow Report
Australia Stock Exchange release from CLINUVEL PHARMAC : PRE_NR Ends: 09:43:51
Australia Stock Exchange release from CLINUVEL PHARMAC : CLINUVEL Newsletter I - January 22
Australia Stock Exchange release from CLINUVEL PHARMAC : SCENESSE Continued in Germany
Australia Stock Exchange release from CLINUVEL PHARMAC : Change of Director's Interest Notice
Australia Stock Exchange release from CLINUVEL PHARMAC : Notification of cessation of securities - CUV
Australia Stock Exchange release from CLINUVEL PHARMAC : CLINUVEL completes enrolment in CUV801 Stroke Study